Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives $7.00 Average Price Target from Analysts
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have been given a consensus recommendation of “Hold” by the six research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month […]
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have been given a consensus recommendation of “Hold” by the six research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month […]
